Direct Oral Anticoagulant Use and Outcomes in Patients with High and Intermediate Risk BCR-ABL-Negative Myeloproliferative Neoplasms

被引：1
|
作者：
Schoenbeck, Kelly L. [1 ]
Salmasi, Giselle [2 ]
Cerejo, Miguel Carlos [2 ]
Cornett, Patricia A. [2 ]
Damon, Lloyd E. [2 ]
Logan, Aaron C. [2 ]
Olin, Rebecca L. [2 ]
Leavitt, Andrew D. [2 ]
Smith, Catherine C. [2 ]
机构：
[1] Univ Calif San Francisco, Div Hematol & Oncol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Div Hematol & Blood & Marrow Transplantat, San Francisco, CA 94143 USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-129705
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1165
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Clinical Study of Lymphocyte Subsets in Patients with BCR/ABL Negative Myeloproliferative Neoplasms
    Li, Fei
    Chen, Ziwei
    Wang, Shixuan
    Yang, Renchi
    BLOOD, 2023, 142
  • [22] Basophilia Predicts Poorer Outcomes in BCR-ABL1-Negative Myeloproliferative Neoplasms
    Yuen, Lisa
    Gogakos, Tasos
    Boiocchi, Leonardo
    Hobbs, Gabriela
    Hasserjian, Robert
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1048 - 1049
  • [23] The evaluation of the relevance of thrombin generation and procoagulant activity in thrombotic risk assessment in BCR-ABL-negative myeloproliferative neoplasm patients
    Baccouche, H.
    Ben Jemaa, M.
    Chakroun, A.
    Chadi, S.
    Mahjoub, S.
    Sfar, I.
    Gorgi, Y.
    Ben Romdhane, N.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2017, 39 (05) : 502 - 507
  • [24] Basophilia Predicts Poorer Outcomes in BCR-ABL1-Negative Myeloproliferative Neoplasms
    Yuen, Lisa
    Gogakos, Tasos
    Boiocchi, Leonardo
    Hobbs, Gabriela
    Hasserjian, Robert
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 1048 - 1049
  • [25] Risk factors of thrombosis in a cohort of 206 patients with BCR-ABL1 negative myeloproliferative neoplasms
    Aswad, Mohamed Hussam
    Kissova, Jarmila
    Ovesna, Petra
    Penka, Miroslav
    NEOPLASMA, 2021, 68 (06) : 1341 - 1350
  • [26] Pathogenetic insight and prognostic information from standard and molecular cytogenetic studies in the BCR-ABL-negative myeloproliferative neoplasms (MPNs)
    Reilly, J. T.
    LEUKEMIA, 2008, 22 (10) : 1818 - 1827
  • [27] Pathogenetic insight and prognostic information from standard and molecular cytogenetic studies in the BCR-ABL-negative myeloproliferative neoplasms (MPNs)
    J T Reilly
    Leukemia, 2008, 22 : 1818 - 1827
  • [28] Allogeneic Stem Cell Transplantation in Patients with BCR-ABL-Negative Myeloproliferative Neoplasms Pretreated with JAK1/JAK2 Inhibitors
    Barabanshikova, Maria
    Morozova, Elena
    Moiseev, Ivan
    Vlasova, Julia
    Baykov, Vadim
    Ushal, Inna
    Rodionov, Gennadij
    Moiseev, Sergey
    Barkhatov, Ildar
    Afanasyeva, Ksenija
    Bondarenko, Sergey
    Afanasyev, Boris
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 402 - 403
  • [29] Impact of target therapy on outcome after allogeneic stem cell transplantation in patients with BCR-ABL-negative myeloproliferative neoplasms: a single center experience
    Barabanshikova, Maria
    Morozova, Elena
    Moiseev, Ivan
    Vlasova, Julia
    Baikov, Vadim
    Barkhatov, Ildar
    Darskaya, Elena
    Bondarenko, Sergey
    Afanasyev, Boris
    BONE MARROW TRANSPLANTATION, 2018, 53 : 245 - 246
  • [30] Oxidant/Antioxidant Status in Patients with BCR-ABL1 Negative Myeloproliferative Neoplasms
    Benguella-Benmansour, Meriem
    Boucherit, Kebir
    Mesli, Naima
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2025, 41 (01) : 23 - 30
12345